Inventor · disambiguated record
Barbara Jagodzinska
Also filed as: JAGODZINSKA BARBARA
16 granted patents·19 pending applications·183 citations·filing 2001–2023
92Inventor score
Top patents by PatentIndex Score
35 records- 0194US7176242B2N,N′-substituted-1,3-diamino-2-hydroxypropane derivativesUPJOHN CO·Filed 2002·Granted Feb 13, 2007·92 cites·20 claims
- 0289US7727997B2N,N′-substituted-1,3-diamino-2-hydroxypropane derivativesELAN PHARM INC·Filed 2006·Granted Jun 1, 2010·21 cites·27 claims
- 0386US6962934B2Substituted amino carboxamides for the treatment of Alzheimer's diseaseUPJOHN CO·Filed 2003·Granted Nov 8, 2005·19 cites·12 claims
- 0482US7385085B2Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitorsELAN PHARM INC·Filed 2005·Granted Jun 10, 2008·6 cites·10 claims
- 0582US7214715B2Compounds to treat Alzheimer's diseaseELAN PHARM INC·Filed 2001·Granted May 8, 2007·18 cites·100 claims
- 0680US7858642B2Substituted hydroxyethylamine aspartyl protease inhibitorsELAN PHARM INC·Filed 2009·Granted Dec 28, 2010·5 cites·24 claims
- 0780US6846813B2Compounds to treat alzheimer's diseaseUPJOHN CO·Filed 2001·Granted Jan 25, 2005·10 cites·72 claims
- 0876US7294642B21,3-Diamino-2-hydroxypropane pro-drug derivativesELAN PHARM INC·Filed 2003·Granted Nov 13, 2007·8 cites·18 claims
- 0968US7338965B23,4-disubstituted, 3,5-disubstituted and 3,4,5-substituted piperidinesUPJOHN CO·Filed 2002·Granted Mar 4, 2008·4 cites·10 claims
- 1066US12157740B2Triazolopyridines and triazolopyrimidines that lower stress-induced p-tauNANTNEURO LLC·Filed 2021·Granted Dec 3, 2024·0 cites·3 claims
- 1159US2022041553A1Apoe4-targeted theraputics that increase sirt1JAGODZINSKA BARBARA·Filed 2021·Application pending·0 cites
- 1258US11370793B2Triazolopyridines and triazolopyrimidines that lower stress-induced p-tauNANTNEURO LLC·Filed 2016·Granted Jun 28, 2022·0 cites·4 claims
- 1357US2023381141A1Conjoint therapies for treating viral infectionsUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 1456US2008161325A11, 3, Diamino-2-Hydroxypropane Pro-Drug DerivativesELAN PHARM INC·Filed 2007·Application pending·0 cites
- 1556US2024083839A1Compositions and methods for treating neurodegenerative diseases and disordersUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 1656US2009042961A1Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitorsELAN PHARM INC·Filed 2008·Application pending·0 cites
- 1755US2024043373A1Compositions and methods for treating amyloid-related conditionsUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 1854US2025019365A1Compositions and methods for preserving and/or restoring neural functionUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 1953US12441716B2Compositions and methods for increasing muscle mass and oxidative metabolismUNIV CALIFORNIA·Filed 2020·Granted Oct 14, 2025·0 cites·5 claims
- 2053US11142505B2Compositions for APP-selective BACE inhibition and uses thereforUNIV CALIFORNIA·Filed 2016·Granted Oct 12, 2021·0 cites·20 claims
- 2150US2017226059A1Apoe4-targeted theraputics that increase sirt1JAGODZINSKA BARBARA·Filed 2015·Application pending·0 cites
- 2249US2023348394A1Compositions and methods for treating muscular dystrophiesUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 2349US2024208935A1Compositions and methods for treating neurodegenerative diseasesUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 2448US2006079533A1Methods of treating alzheimer's diseaseNIEMAN JAMES A·Filed 2002·Application pending·0 cites
- 2548US2007213407A1Compounds to treat Alzheimer's diseaseELAN PHARMACEUTICALS AND PHARM·Filed 2006·Application pending·0 cites
- 2647US2023113944A1Compositions and methods for the treatment of neurodegenerative diseasesUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 2746US11077108B2Allosteric corticotropin-releasing factor receptor 1 (CRFR1) antagonists that decrease p-tau and improve cognitionUNIV CALIFORNIA·Filed 2017·Granted Aug 3, 2021·0 cites·14 claims
- 2844US2022305006A1Compositions and methods for the treatment of neurological diseases and disordersUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 2943US7906556B2Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitorsELAN PHARM INC·Filed 2006·Granted Mar 15, 2011·0 cites·18 claims
- 3042US7498436B2Substituted hydroxyethylaminesPHARMACIA & UPJOHN CO LLC·Filed 2003·Granted Mar 3, 2009·0 cites·7 claims
- 3142US2005239836A1Substituted hydroxyethylamine aspartyl protease inhibitorsJOHN VARGHESE·Filed 2005·Application pending·0 cites
- 3241US2021101879A1AMYLOID PROTEIN-SELECTIVE BACE INHIBITORS (ASBIs) FOR ALZHEIMER?S DISEASEUNIV CALIFORNIA·Filed 2019·Application pending·0 cites
- 3337US2019134000A1Compounds to promote normal processing of appBUCK INST RES AGING·Filed 2017·Application pending·0 cites
- 3436US2020270216A1Compositions and methods for inhibiting n-smase2BILOUSOVA TINA·Filed 2018·Application pending·0 cites
- 3534US2005239790A1Substituted hydroxyethylamine aspartyl protease inhibitorsJOHN VARGHESE·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →